Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Major Depressive Disorder Study In Adults Clinical Trials Information presented on Clinical Trials Search isn't intended to be a substitute for proven healthcare advice, trips or treatment using a real physician. We are not docs. Always confer with your mD on Major Depressive Disorder Study In Adults conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Major Depressive Disorder Study In Adults Clinical research trials and Major Depressive Disorder Study In Adults medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectiveness of new drugs. The intention of the studies / projects is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector corporations to detect remedies for all forms of circumstances, like Major Depressive Disorder Study In Adults. Major Depressive Disorder Study In Adults Clinical Trials and other clinical trials allow for volunteers to undergo healthcare treatment options before they are available to the masses. Most times the participants receive treatment for free, and every now and again they are paid for their time. Occasionally there is a cost for a Major Depressive Disorder Study In Adults clinical trial. Subjects typically recieve the finest healthcare available for their Major Depressive Disorder Study In Adults condition. Hazards are a reality, nonetheless, and might include more or frequent mD trips, health risks (potentially life-endangering), and/or the treatment being ineffective. Trials are federally regulated with stern guidelines to protect clinical trials subjects.

Home > "M" Clinical Trials Conditions > Major Depressive Disorder Study In Adults

Major Depressive Disorder Study In Adults



Major Depressive Disorder Study In Adults

For Condition: Major Depressive Disorder
Status: Completed
Sponsor(s): Sponsor Name Pending ,
Synopsis: A study to obtain safety and tolerability data
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion: (Patients must meet the following criteria in order to be eligible for this study.) - Patient must have primary diagnosis of Major Depressive Disorder (MDD). - Discontinued a selective serotonin reuptake inhibitor (SSRI)or serotonin-norepinephrine reuptake inhibitor (SNRI) regimen due to intolerability. - Minimum time frame between last dose of previous antidepressant and initiation of study drug is one week. - Maximum time frame between last dose of prior antidepressant and initiation of study drug is 2 months. Exclusion: (Patients cannot meet the following criteria in order to be eligible for this study.) - Patient has previously been treated with the study drug. - Is experiencing an adverse event attributed to previous SSRI/SNRI use that has not been resolved at least one week prior to Baseline Visit. - Has a history of seizure disorder. - Has met criteris for substance abuse or dependence within 6 months prior to Baseline Visit. - Currently using an antidepressant. - Currently pregnant.
Total Enrollment: 

Location and Contact Information:

Study Site
Mobile,  Alabama,  36695
United States
 

Study Site
West Valley City,  Utah,  84120
United States
 

Study Site
Kirkland,  Washington,  98034
United States
 

Study Site
Little Rock,  Arkansas,  72111
United States
 

Study Site
Clovis,  California,  93611
United States
 

Study Site
Galveston,  Texas,  77555
United States
 

Study Site
Richmond,  Virginia,  23230
United States
 

Study Site
Sacramento,  California,  95823
United States
 

Study Site
San Francisco,  California,  94109
United States
 

Study Site
Ft. Worth,  Texas,  76137
United States
 

Study Site
Vista,  California,  92083
United States
 

Study Site
Fairfield,  Alabama,  35064
United States
 

Study Site
Ft. Myers,  Florida,  33901
United States
 

Study Site
Lake Charles,  Louisiana,  70601
United States
 

Study Site
Lafayette,  Louisiana,  47905
United States
 

Study Site
Springfield,  Massachusetts,  01107
United States
 

Study Site
St. Charles,  Missouri,  63301
United States
 

Study Site
Little Rock,  Arkansas,  72205
United States
 

Study Site
Oklahoma City,  Oklahoma,  73112
United States
 

Study Site
Sugar Land,  Texas,  77478
United States
 

Study Site
Greenwood,  Indiana,  46143
United States
 

Study Site
Atlanta,  Georgia,  30312
United States
 

Study Site
Bellflower,  California,  90706
United States
 

Study Site
Riverside,  California,  92506
United States
 

Study Site
Kansas City,  Missouri,  64132
United States
 

Study Site
Downingtown,  Pennsylvania,  19335
United States
 

Study Site
Mercerville,  New Jersey,  08619
United States
 

Study Site
Prince Frederick,  Maryland,  20678
United States
 

Study Site
Cincinnati,  Ohio,  45219
United States
 

Study Site
Cordova,  Tennessee,  38018
United States
 

Study Site
Melbourne,  Florida,  32955
United States
 

Study Site
Cincinnati,  Ohio,  45224
United States
 

Study Site
Phoenix,  Arizona,  85015
United States
 

Study Site
Independence,  Ohio,  44131
United States
 

Study Site
St. Louis,  Missouri,  63128
United States
 

Study Site
Birmingham,  Alabama,  83704
United States
 

Study Site
Indianapolis,  Indiana,  46227
United States
 

Study Site
Lebanon,  Virginia,  24266
United States
 

Study Site
Conroe,  Texas,  77384
United States
 

Study Site
Miami,  Florida,  33161
United States
 

Study Site
Cerritos,  California,  90703
United States
 

Study Site
Delray Beach,  Florida,  33484
United States
 

Study Site
Wilmington,  Delaware,  19810
United States
 

Study Site
Blackwood,  New Jersey,  08012
United States
 

Study Site
Cleveland,  Ohio,  44106
United States
 

Study Site
Colorado Springs,  Colorado,  80904
United States
 

Study Site
Las Vegas,  Nevada,  89030
United States
 

Study Site
Idaho Falls,  Idaho,  83404
United States
 

Study Site
Sacramento,  California,  95825
United States
 

Study Site
Gurnee,  Illinois,  60031
United States
 

Study Site
Miami,  Florida,  33161
United States
 

Study Site
Dallas,  Texas,  72505
United States
 

Study Site
Cary,  North Carolina,  27511
United States
 

Study Site
Ocala,  Florida,  34474
United States
 

Study Site
Selmer,  Tennessee,  38375
United States
 

Study Site
Excelsior Springs,  Missouri,  64024
United States
 

Study Site
Carrboro,  North Carolina,  27510
United States
 

Study Site
Corsicana,  Texas,  75110
United States
 

Study Site
Petaluma,  California,  94952
United States
 

Study Site
Boynton Beach,  Florida,  33426
United States
 

Study Site
Birmingham,  Alabama,  35209
United States
 

Study Site
New Orleans,  Louisiana,  70127
United States
 

Study Site
Reno,  Nevada,  89501
United States
 

Study Site
Bartlett,  Tennessee,  38134
United States
 

Study Site
Desoto,  Texas,  75115
United States
 

Study Site
Temecula,  California,  92591
United States
 

Study Site
Princeton,  New Jersey,  08540
United States
 

Study Site
Encino,  California,  91316
United States
 

Study Site
Anaheim,  California,  92801
United States
 

Study Site
Eugene,  Oregon,  97404
United States
 

Study Site
Wilmington,  Delaware,  19803
United States
 

Study Site
Anaheim Hills,  California,  92807
United States
 


Additional Information:
Study ID Numbers:
  SB29060.833; 
Study Start Date: 
Record last reviewed: January 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00049972

Other Major Depressive Disorder Studies:
1. Open-Label Treatment with Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients with Major Depression

2. Study Of Adults With Depression

3. Brain Function in Mentally Ill Adolescents

4. Brain Chemical Receptor Effects in Patients with Panic Disorder and Post-Traumatic Stress Disorder

5. Continuation Electroconvulsive Therapy vs Medication to Prevent Relapses in Patients with Major Depressive Disorder

Related Studies:

Other Major Depressive Disorder Clinical Trials
Other Texas Clinical Trials
Other Dallas Clinical Trials

Major Depressive Disorder Study In Adults

Modify your Search

  Other Major Depressive Disorder Clinical Trials
  Other Texas Clinical Trials
  Other Dallas Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103